RCBTB1

gene product
CLLD7, CLLL7, FLJ10716
This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex, tramtrack and bric-a-brac) domain. In rat, over-expression of this gene in vascular smooth muscle cells induced cellular hypertrophy. In rat, the C-terminus of RCBTB1 interacts with the angiotensin II receptor-1A. In humans, this gene maps to a region of chromosome 13q that is frequently deleted in B-cell chronic lymphocytic leukemia and other lymphoid malignancies. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
231 antibodies from 27 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Invitrogen Antibodies
4 antibodies
antibodies-online
90 antibodies
LifeSpan BioSciences, Inc.
25 antibodies
GeneTex
2 antibodies
Affinity Biosciences
1 antibody
Novus Biologicals
5 antibodies
Biorbyt
13 antibodies
Abnova Corporation
5 antibodies
OriGene
3 antibodies
Acris Antibodies GmbH
2 antibodies
Bioworld Technology, Inc
1 antibody
Proteintech Group
1 antibody
Boster Biological Technology
1 antibody
NovoPro Bioscience Inc.
1 antibody
Abgent
2 antibodies
Atlas Antibodies
1 antibody
Aviva Systems Biology
1 antibody
St John's Laboratory
2 antibodies
MyBioSource
5 antibodies
Creative Diagnostics
5 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
United States Biological
26 antibodies
Creative Biolabs
1 antibody
Leading Biology
1 antibody
ProSci
1 antibody
Sigma-Aldrich
1 antibody